A detailed history of Lcnb Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Lcnb Corp holds 14,938 shares of JNJ stock, worth $2.18 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
14,938
Previous 14,854 0.57%
Holding current value
$2.18 Million
Previous $2.33 Million 1.5%
% of portfolio
0.86%
Previous 0.92%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $13,038 - $13,670
84 Added 0.57%
14,938 $2.36 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $32,468 - $35,430
223 Added 1.52%
14,854 $2.33 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $264,152 - $295,918
-1,696 Reduced 10.39%
14,631 $2.28 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $4,321 - $4,651
28 Added 0.17%
16,327 $2.7 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $27,340 - $32,627
-181 Reduced 1.1%
16,299 $2.53 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $99,324 - $111,469
-620 Reduced 3.63%
16,480 $2.91 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $122,610 - $136,435
-760 Reduced 4.26%
17,100 $2.79 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $54,829 - $60,639
-326 Reduced 1.79%
17,860 $3.17 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $163,674 - $185,875
1,035 Added 6.03%
18,186 $3.22 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $65,646 - $72,837
421 Added 2.52%
17,151 $2.93 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $65,407 - $72,685
405 Added 2.48%
16,730 $2.7 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $106,054 - $113,761
665 Added 4.25%
16,325 $2.69 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $123,221 - $137,236
-805 Reduced 4.89%
15,660 $2.57 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $10,968 - $12,590
80 Added 0.49%
16,465 $2.59 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $40,429 - $44,303
-288 Reduced 1.73%
16,385 $2.44 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $32,073 - $38,721
-249 Reduced 1.47%
16,673 $2.35 Million
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $79,242 - $109,794
713 Added 4.4%
16,922 $2.22 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $4,972 - $5,711
39 Added 0.24%
16,209 $2.36 Million
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $141,295 - $158,201
1,113 Added 7.39%
16,170 $2.09 Million
Q2 2019

Aug 01, 2019

SELL
$131.15 - $144.24 $8,524 - $9,375
-65 Reduced 0.43%
15,057 $2.1 Million
Q1 2019

May 02, 2019

SELL
$125.72 - $139.79 $19,738 - $21,947
-157 Reduced 1.03%
15,122 $2.11 Million
Q4 2018

Feb 19, 2019

BUY
$122.84 - $147.84 $50,364 - $60,614
410 Added 2.76%
15,279 $1.97 Million
Q3 2018

Nov 09, 2018

BUY
$121.58 - $142.88 $3,039 - $3,572
25 Added 0.17%
14,869 $2.05 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $30,327 - $33,467
254 Added 1.74%
14,844 $1.8 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $2,627 - $3,110
-21 Reduced 0.14%
14,590 $1.87 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $27,293 - $29,872
208 Added 1.44%
14,611 $2.04 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $4,531 - $4,738
35 Added 0.24%
14,403 $1.87 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,368
14,368 $1.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Lcnb Corp Portfolio

Follow Lcnb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.